CVE-2020-10004

Description

A logic issue was addressed with improved state management. This issue is fixed in macOS Big Sur 11.0.1, iOS 14.2 and iPadOS 14.2. Opening a maliciously crafted file may lead to unexpected application termination or arbitrary code execution.

7.8

CVSS

Severity: High

CVSS 3.1 •

CVSS 2.0 •

EPSS 0.56%

Vendor Advisory apple.com Vendor Advisory apple.com Vendor Advisory apple.com Vendor Advisory apple.com

Affected: Apple iOS and iPadOS

Affected: Apple macOS

References

Link	Tags
https://support.apple.com/kb/HT211930	vendor advisory
https://support.apple.com/en-us/HT211931	vendor advisory
https://support.apple.com/en-us/HT211929	vendor advisory
https://support.apple.com/kb/HT212011	vendor advisory
http://seclists.org/fulldisclosure/2020/Dec/32	third party advisory mailing list
http://seclists.org/fulldisclosure/2020/Dec/26	third party advisory mailing list

Frequently Asked Questions

What is the severity of CVE-2020-10004?: CVE-2020-10004 has been scored as a high severity vulnerability.
How to fix CVE-2020-10004?: To fix CVE-2020-10004, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2020-10004 being actively exploited in the wild?: As for now, there are no information to confirm that CVE-2020-10004 is being actively exploited. According to its EPSS score, there is a ~1% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
What software or system is affected by CVE-2020-10004?: CVE-2020-10004 affects Apple iOS and iPadOS, Apple macOS.

This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.